Dr. Cristiano Luis Dias' lab focuses on understanding how specific sequences of amino acids in peptides influence their ability to form structures known as amyloid fibrils, which are implicated in diseases like Alzheimer's and Parkinson's. By combining advanced computer simulations, machine learning, and experimental validation, the lab aims to develop predictive tools that can identify the potential for peptide self-assembly. This research is important for designing non-toxic amyloids for biomedical applications and improving our understanding of peptide behavior in the context of neurodegenerative diseases.